Published in J Econ Perspect on January 01, 2011
Large increases in spending on postacute care in Medicare point to the potential for cost savings in these settings. Health Aff (Millwood) (2013) 1.97
Feasibility of surgical randomised controlled trials with a placebo arm: a systematic review. BMJ Open (2016) 0.80
The end of hospital cost shifting and the quest for hospital productivity. Health Serv Res (2013) 0.77
Trends in PCI volume after negative results from the COURAGE trial. Health Serv Res (2013) 0.76
Paying on the margin for medical care: Evidence from breast cancer treatments. Am Econ J Econ Policy (2016) 0.75
In the Shadow of a Giant: Medicare's Influence on Private Physician Payments. J Polit Econ (2016) 0.75
Computed tomography--an increasing source of radiation exposure. N Engl J Med (2007) 41.06
Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med (2010) 29.06
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
The price of innovation: new estimates of drug development costs. J Health Econ (2003) 23.43
Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med (2000) 19.56
A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med (2002) 16.75
Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA (1994) 11.32
Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med (2008) 7.75
Setting health care priorities in Oregon. Cost-effectiveness meets the rule of rescue. JAMA (1991) 6.11
Is technological change in medicine worth it? Health Aff (Millwood) (2001) 5.97
Estimating the cost of new drug development: is it really 802 million dollars? Health Aff (Millwood) (2006) 4.84
Is technological change in medicine always worth it? The case of acute myocardial infarction. Health Aff (Millwood) (2006) 4.80
Discretionary decision making by primary care physicians and the cost of U.S. Health care. Health Aff (Millwood) (2008) 4.30
Economic foundations of cost-effectiveness analysis. J Health Econ (1997) 3.33
Value-based insurance design. Health Aff (Millwood) (2007) 3.27
Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA (1998) 3.19
Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease. Ann Intern Med (2010) 2.92
Comparative effectiveness and health care spending--implications for reform. N Engl J Med (2010) 2.81
How Medicare could use comparative effectiveness research in deciding on new coverage and reimbursement. Health Aff (Millwood) (2010) 2.68
An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard. Value Health (2009) 2.60
Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. JAMA (2000) 2.59
Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease. J Gen Intern Med (2000) 2.21
Does comparative-effectiveness research threaten personalized medicine? N Engl J Med (2009) 2.20
Identifying and eliminating the roadblocks to comparative-effectiveness research. N Engl J Med (2010) 1.84
Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making (2002) 1.78
Limited good and limited vision: multidrug-resistant tuberculosis and global health policy. Soc Sci Med (2005) 1.66
Court-ordered reimbursement for unproven medical technology. Circumventing technology assessment. JAMA (1993) 1.64
Responding to an FDA warning--geographic variation in the use of rosiglitazone. N Engl J Med (2010) 1.46
Is American health care uniquely inefficient? J Econ Perspect (2008) 1.42
Accounting for future costs in medical cost-effectiveness analysis. J Health Econ (1997) 1.41
Medicaid's prior authorization program and access to atypical antipsychotic medications. Health Aff (Millwood) (2007) 1.38
Assessing health reform's impact on four key groups of Americans. Health Aff (Millwood) (2010) 1.15
Who cares about cost? Does economic analysis impose or reflect social values? Health Policy (1995) 1.13
The role of costs in comparative effectiveness research. Health Aff (Millwood) (2010) 1.12
Knee arthroscopy in England and Ontario: patterns of use, changes over time, and relationship to total knee replacement. J Bone Joint Surg Am (2008) 1.09
The impact of comparative effectiveness research on health and health care spending. J Health Econ (2011) 0.98
The potential impact of comparative effectiveness research on U.S. health care expenditures. Demography (2010) 0.93
Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation. Health Technol Assess (2005) 0.89
Time for clinically relevant comparative effectiveness studies in type 2 diabetes. Ann Intern Med (2010) 0.84
Uncomfortable arithmetic--whom to cover versus what to cover. N Engl J Med (2009) 0.78
The economics of comparative effectiveness research. Neurology (2010) 0.76
Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial. JAMA (2006) 12.22
Geography and the debate over Medicare reform. Health Aff (Millwood) (2003) 9.85
Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT) observational cohort. JAMA (2006) 7.45
Are regional variations in end-of-life care intensity explained by patient preferences?: A Study of the US Medicare Population. Med Care (2007) 5.42
Design of the Spine Patient outcomes Research Trial (SPORT). Spine (Phila Pa 1976) (2002) 4.42
Spending differences associated with the Medicare Physician Group Practice Demonstration. JAMA (2012) 4.32
Who you are and where you live: how race and geography affect the treatment of medicare beneficiaries. Health Aff (Millwood) (2004) 4.25
Surgical treatment of spinal stenosis with and without degenerative spondylolisthesis: cost-effectiveness after 2 years. Ann Intern Med (2008) 3.65
Fostering accountable health care: moving forward in medicare. Health Aff (Millwood) (2009) 3.52
Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare-age men. J Clin Oncol (2012) 3.35
Slowing the growth of health care costs--lessons from regional variation. N Engl J Med (2009) 3.21
Prespecified falsification end points: can they validate true observational associations? JAMA (2013) 3.11
Hospital quality and the cost of inpatient surgery in the United States. Ann Surg (2012) 3.04
Trends in the earnings of male and female health care professionals in the United States, 1987 to 2010. JAMA Intern Med (2013) 2.97
Getting past denial--the high cost of health care in the United States. N Engl J Med (2009) 2.88
Why physicians work when sick. Arch Intern Med (2012) 2.65
Geographic variation in health care and the problem of measuring racial disparities. Perspect Biol Med (2005) 2.53
Geographic variation in diagnosis frequency and risk of death among Medicare beneficiaries. JAMA (2011) 2.53
Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents. JAMA (2008) 2.47
Prices don't drive regional Medicare spending variations. Health Aff (Millwood) (2010) 2.44
Relationship between regional per capita Medicare expenditures and patient perceptions of quality of care. JAMA (2008) 2.31
On average, physicians spend nearly 11 percent of their 40-year careers with an open, unresolved malpractice claim. Health Aff (Millwood) (2013) 2.26
Medicare payments for common inpatient procedures: implications for episode-based payment bundling. Health Serv Res (2010) 2.18
The European Working Time Directive: an uncontrolled experiment in medical care and education. JAMA (2013) 2.10
Heterogeneity in action: the role of passive personalization in comparative effectiveness research. Health Econ (2013) 2.04
Out-of-pocket spending in the last five years of life. J Gen Intern Med (2012) 1.95
How much do patients' preferences contribute to resource use? Health Aff (Millwood) (2009) 1.88
Out-of-pocket medication costs and use of medications and health care services among children with asthma. JAMA (2012) 1.83
Hospital spending and inpatient mortality: evidence from California: an observational study. Ann Intern Med (2011) 1.79
Hospital quality and intensity of spending: is there an association? Health Aff (Millwood) (2009) 1.77
The cost effectiveness of surgical versus nonoperative treatment for lumbar disc herniation over two years: evidence from the Spine Patient Outcomes Research Trial (SPORT). Spine (Phila Pa 1976) (2008) 1.72
The Burden of Health Care Costs for Patients With Dementia in the Last 5 Years of Life. Ann Intern Med (2015) 1.60
Growth in medicare expenditures for patients with acute myocardial infarction: a comparison of 1998 through 1999 and 2008. JAMA Intern Med (2013) 1.50
Drug licenses: a new model for pharmaceutical pricing. Health Aff (Millwood) (2008) 1.39
Will volume-based referral strategies reduce costs or just save lives? Health Aff (Millwood) (2002) 1.32
The value of specialty oncology drugs. Health Serv Res (2009) 1.24
Hospital value-based purchasing. J Hosp Med (2013) 1.21
The impact of workers' compensation on outcomes of surgical and nonoperative therapy for patients with a lumbar disc herniation: SPORT. Spine (Phila Pa 1976) (2010) 1.16
Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and regional variation. Med Care (2014) 1.16
Inpatient care intensity and patients' ratings of their hospital experiences. Health Aff (Millwood) (2009) 1.13
An economic evaluation of the war on cancer. J Health Econ (2010) 1.13
The promise of health care cost containment. Health Aff (Millwood) (2007) 1.13
Decision-making process reported by Medicare patients who had coronary artery stenting or surgery for prostate cancer. J Gen Intern Med (2012) 1.12
Outcomes of Basic Versus Advanced Life Support for Out-of-Hospital Medical Emergencies. Ann Intern Med (2015) 1.02
Extending the P4P agenda, part 2: how Medicare can reduce waste and improve the care of the chronically ill. Health Aff (Millwood) (2007) 1.02
Medicare part D after 2 years. Am J Manag Care (2009) 0.99
The impact of comparative effectiveness research on health and health care spending. J Health Econ (2011) 0.98
Trends in the earnings of health care professionals in the United States, 1987-2010. JAMA (2012) 0.97
Social security and mental illness: reducing disability with supported employment. Health Aff (Millwood) (2009) 0.96
Spending and mortality in US acute care hospitals. Am J Manag Care (2013) 0.93
Impact of payment reform on chemotherapy at the end of life. J Oncol Pract (2012) 0.93
Predicting new diagnoses of HIV infection using internet search engine data. Clin Infect Dis (2013) 0.91
McAllen And El Paso revisited: Medicare variations not always reflected in the under-sixty-five population. Health Aff (Millwood) (2010) 0.89
Guidance for structuring team-based incentives in healthcare. Am J Manag Care (2013) 0.89
Impact of payment reform on chemotherapy at the end of life. Am J Manag Care (2012) 0.89
Defense costs of medical malpractice claims. N Engl J Med (2012) 0.89
Reducing Diagnostic Errors--Why Now? N Engl J Med (2015) 0.89
The economics of intense exercise. J Health Econ (2010) 0.87
Association between physician supply, local practice norms, and outpatient visit rates. Med Care (2013) 0.86
A population health approach to reducing observational intensity bias in health risk adjustment: cross sectional analysis of insurance claims. BMJ (2014) 0.84
Effect of hospital use of oral nutritional supplementation on length of stay, hospital cost, and 30-day readmissions among Medicare patients with COPD. Chest (2015) 0.81
Postinterview communication between military residency applicants and training programs. Mil Med (2012) 0.81
Falsification end points for observational studies--reply. JAMA (2013) 0.77
Balancing disease eradication with the emergence of multidrug-resistant HIV in test-and-treat policies. Clin Infect Dis (2013) 0.76
Community-acquired pneumonia and proton pump inhibitors. J Gen Intern Med (2013) 0.75
Duty hour reforms in Europe and the United States--reply. JAMA (2013) 0.75
Striking a balance on new technology. Cost-effectiveness analysis can help sort out emerging health care technologies, but what are the consequences for continued medical innovation? AHIP Cover (2006) 0.75
Response to Epstein's comment on "heterogeneity in action". Health Econ (2014) 0.75
Social desirability bias in self-rated presenteeism among resident physicians--reply. JAMA Intern Med (2013) 0.75
The Institute of Medicine report on the FDA: where is the science? Health Econ (2007) 0.75
Outcomes of Basic Versus Advanced Life Support for Out-of-Hospital Medical Emergencies. Ann Intern Med (2016) 0.75
Is Prehospital Advanced Life Support Harmful? Ann Intern Med (2016) 0.75
Chronic Condition Measurement Requires Engagement, Not Measurement Alone. J Ambul Care Manage (1) 0.75